Kunal P. Raygor

Kunal P. Raygor

Auto-generated profile, based on publicly available information

Kunal P. Raygor

Laboratory for Accelerated Vascular Research, Department of Surgery (X.Z., K.A.J., K.P.R., S.L., Jiakun Li, X.W., Jiajun Li, P.H.H., R.A.W.), University of California, San Francisco

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in Science
Verified
Journal Article
Closed access
EWEthan A. Winkler
Ethan A. Winkler
CKChang N. Kim
Chang N. Kim
JRJayden M. Ross
Jayden M. Ross
JGJoseph H. Garcia
Joseph H. Garcia
EGEugene Gil
Eugene Gil
TNTomasz Jan Nowakowski
Tomasz Jan Nowakowski
Cerebrovascular diseases are a leading cause of death and neurologic disability. Further understanding of disease mechanisms and therapeutic strategies requires a deeper knowledge of cerebrovascular cells in humans. We profiled transcriptomes of 181,388 cells to define a cell atlas of the adult human cerebrovasculature, including endothelial cell molecular signatures with arteriovenous segmentation and expanded perivascular cell diversity. By leveraging this reference, we investigated cellular and molecular perturbations in brain arteriovenous malformations, which are a leading cause of stroke in young people, and identified pathologic endothelial transformations with abnormal vascular patterning and the ontology of vascularly derived inflammation. We illustrate the interplay between vascular and immune cells that contributes to brain hemorrhage and catalog opportunities for targeting angiogenic and inflammatory programs in vascular malformations.

28 November 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CNCorinne M. Nielsen
Corinne M. Nielsen
XZXuetao Zhang
Xuetao Zhang
KRKunal Raygor
Kunal Raygor
SWShaoxun Wang
Shaoxun Wang
ABAndrew W. Bollen
Andrew W. Bollen
RWRong A. Wang
Rong A. Wang
Upregulation of Notch signaling is associated with brain arteriovenous malformation (bAVM), a disease that lacks pharmacological treatments. Tetracycline (tet)-regulatable endothelial expression of constitutively active Notch4 (Notch4*tetEC) from birth induced bAVMs in 100% of mice by P16. To test whether targeting downstream signaling, while sustaining the causal Notch4*tetEC expression, induces AVM normalization, we deleted Rbpj, a mediator of Notch signaling, in endothelium from P16, by combining tet-repressible Notch4*tetEC with tamoxifen-inducible Rbpj deletion. Established pathologies, including AV connection diameter, AV shunting, vessel tortuosity, intracerebral hemorrhage, tissue hypoxia, life expectancy, and arterial marker expression were improved, compared with Notch4*tetEC mice without Rbpj deletion. Similarly, Rbpj deletion from P21 induced advanced bAVM regression. After complete AVM normalization induced by repression of Notch4*tetEC, virtually no bAVM relapsed, despite Notch4*tetEC re-expression in adults. Thus, inhibition of endothelial Rbpj halted Notch4*tetEC bAVM progression, normalized bAVM abnormalities, and restored microcirculation, providing proof of concept for targeting a downstream mediator to treat AVM pathologies despite a sustained causal molecular lesion.

22 July 2022 in Neurosurgery
Verified
Journal Article
Closed access
SMSolmaz P Manuel
Solmaz P Manuel
ZCZer Keen Chia
Zer Keen Chia
KRKunal P. Raygor
Kunal P. Raygor
AFAlicia Fernández
Alicia Fernández
BACKGROUND: Little is known about the independent association of language barriers on postoperative process outcomes after craniotomies. OBJECTIVE: To evaluate the association of limited English proficiency (LEP) with length of stay (LOS), discharge disposition, hospitalization costs, and rate of 30-day readmission after craniotomy for brain tumor. METHODS: This is a retrospective cohort study of adult patients who underwent craniotomies for brain tumor from 2015 to 2019 at a high-volume neurosurgical center. Multivariable logistic regression was used to evaluate the association of LEP with discharge disposition and 30‐day readmission. Negative binomial regression was used to evaluate the association of LEP with LOS and hospitalization cost. RESULTS: Of the 2232 patients included, 7% had LEP. LEP patients had longer LOS (median [IQR] 5 [3-8] days vs 3 [2-5] days, P < .001), higher costs of hospitalization (median [IQR] $27 000 [$21 000-$36 000] vs $23 000 [$19 000-$30 000], P < .001), and were more likely to be discharged to skilled care facilities (37% vs 21%, P < .001) compared with English proficient patients. In multivariable models, the association between LEP and longer LOS (incidence rate ratio 1.11, 95% CI 1.00-1.24), higher hospitalization costs (incidence rate ratio 1.13, 95% CI 1.05-1.20), and discharge to skilled care (OR 1.76, 95% CI 1.13-2.72) remained after adjusting for confounders. There was no difference in 30-day readmission rates by language status. CONCLUSION: LEP is an independent risk factor for extended LOS, higher hospitalization cost, and discharge to skilled care in neurosurgical patients who undergo craniotomy for brain tumor. Future research should seek to understand mediators of these observed disparities.

26 May 2023 in Science Advances
Verified
Journal Article
Closed access
LHLawrence Huang
Lawrence Huang
FCFeng Cheng
Feng Cheng
XZXuetao Zhang
Xuetao Zhang
Jacek ZielonkaJacek Zielonka
Jacek Zielonka
MNMatthew A Nystoriak
Matthew A Nystoriak
RWRong A. Wang
Rong A. Wang
Mechanisms underlying arteriovenous malformations (AVMs) are poorly understood. Using mice with endothelial cell (EC) expression of constitutively active Notch4 (Notch4* EC ), we show decreased arteriolar tone in vivo during brain AVM initiation. Reduced vascular tone is a primary effect of Notch4* EC , as isolated pial arteries from asymptomatic mice exhibited reduced pressure-induced arterial tone ex vivo. The nitric oxide (NO) synthase (NOS) inhibitor NG-nitro- l -arginine (L-NNA) corrected vascular tone defects in both assays. L-NNA treatment or endothelial NOS ( eNOS ) gene deletion, either globally or specifically in ECs, attenuated AVM initiation, assessed by decreased AVM diameter and delayed time to moribund. Administering nitroxide antioxidant 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl also attenuated AVM initiation. Increased NOS-dependent production of hydrogen peroxide, but not NO, superoxide, or peroxynitrite was detected in isolated Notch4* EC brain vessels during AVM initiation. Our data suggest that eNOS is involved in Notch4* EC -mediated AVM formation by up-regulating hydrogen peroxide and reducing vascular tone, thereby permitting AVM initiation and progression.

1 August 2021 in World Neurosurgery
Verified
Journal Article
Closed access
CRCaleb Rutledge
Caleb Rutledge
DRDaniel M.S. Raper
Daniel M.S. Raper
SJSoren Jonzzon
Soren Jonzzon
KRKunal P. Raygor
Kunal P. Raygor
MPMatheus Prado Pereira
Matheus Prado Pereira
AAAdib A. Abla
Adib A. Abla

1 August 2022 in World Neurosurgery
Verified
Journal Article
Open access
KRKunal P. Raygor
Kunal P. Raygor
JGJoseph Garcia
Joseph Garcia
CRCaleb Rutledge
Caleb Rutledge
DTDaniel A. Tonetti
Daniel A. Tonetti
DRDaniel M.S. Raper
Daniel M.S. Raper
AAAdib A. Abla
Adib A. Abla
The lateral supraorbital (LSO) approach is a minimally invasive modification of the standard pterional approach to anterior circulation aneurysms. This study aimed to describe a dual-trained cerebrovascular neurosurgeon's first 18-month experience with the LSO approach, including decision-making criteria and lessons learned. This retrospective case series analyzed 50 consecutive patients treated with LSO craniotomy for aneurysm clipping by a single surgeon. Aneurysms were separated into 3 categories by location: internal carotid artery, anterior communicating artery, and middle cerebral artery. Surgical characteristics were evaluated for differences by location and rupture status. Aneurysm clipping via LSO was performed on 57 aneurysms in 50 patients. Fixed retraction was employed less often in patients with internal carotid artery aneurysms than in patients with anterior communicating artery, middle cerebral artery, or multiple aneurysms (10% vs. 68.2%, 45.5%, and 42.9, P = 0.02). Of patients, 26 (52%) presented with subarachnoid hemorrhage; the majority of patients (92.3%) had Hunt and Hess grade I-III. No differences were noted in intraoperative rupture rates, fixed retractor use, operative duration, or estimated blood loss by rupture status. Adverse events included permanent frontalis nerve palsy in 1 patient (2%), temporalis atrophy in 1 patient, and transient aphasia in 1 patient. No postoperative hematomas or strokes were observed. The LSO approach can safely and effectively treat anterior circulation aneurysms and should be considered a viable minimally invasive option for aneurysm clipping. Further studies comparing the LSO approach with other cranial approaches are needed.